SLP (Simulations Plus) Net Margin %: 18.67% (As of Feb. 2026) — 18% Below Median


SLP Simulations Plus Inc SLP
81 GF Score
Price $18.38
GF Value $38.31
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus Net Margin %?

Simulations Plus SLP +0.22% 81 Net Margin % is 18.67% as of Feb. 2026, which is 18% below its 10-year median of 22.80. GuruFocus rates SLP with a GF Score™ of 81/100 and a GF Value™ of $38.31 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Simulations Plus ranks worse than 89.16% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Simulations Plus's Net Income for the three months ended in Feb. 2026 was $4.54 Mil. Simulations Plus's Revenue for the three months ended in Feb. 2026 was $24.29 Mil. Therefore, Simulations Plus's net margin for the quarter that ended in Feb. 2026 was 18.67%.

The historical rank and industry rank for Simulations Plus's Net Margin % or its related term are showing as below:

SLP' s Net Margin % Range Over the Past 10 Years
Min: -81.74   Med: 22.8   Max: 30.12
Current: -77.96


SLP's Net Margin % is ranked worse than
89.16% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 2.915 vs SLP: -77.96

Simulations Plus  (NAS:SLP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Simulations Plus Net Margin % Related Terms


Simulations Plus Net Margin % Historical Data

* Premium members only.

The historical data trend for Simulations Plus's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simulations Plus Net Margin % Chart

Simulations Plus Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.05 23.16 16.72 14.22 -81.74

Simulations Plus Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.70 -330.58 -3.90 3.67 18.67

SLP vs TBRG, CARL, NRC: Net Margin % Comparison

For the Health Information Services subindustry, Simulations Plus's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Net Margin % distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Net Margin % falls into.


SLP
81GF Score
Simulations Plus Inc SLP
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simulations Plus Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Simulations Plus's Net Margin for the fiscal year that ended in Aug. 2025 is calculated as

Net Margin=Net Income (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=-64.718/79.179
=-81.74 %

Simulations Plus's Net Margin for the quarter that ended in Feb. 2026 is calculated as

Net Margin=Net Income (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=4.535/24.291
=18.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 18.67% mean?
Simulations Plus (SLP) has a Net Margin % of 18.67% as of Feb. 2026. Net margin is the ratio of total net income to net sales. View historical data on Simulations Plus and its competitors. This is 18% below median its historical median of 22.80. According to the industry distribution chart, Simulations Plus ranks #592 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 89.2%.
Is Simulations Plus' Net Margin % too high?
Simulations Plus' current Net Margin % of 18.67% is 18% below median its 10-year median of 22.80. The Healthcare Providers & Services industry median Net Margin % is 2.92. Simulations Plus' value of 18.67% is 540.5% above this industry median. Based on the distribution chart, Simulations Plus ranks #592 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Simulations Plus has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Net Margin % compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #592 out of 664 companies for Net Margin %. This places Simulations Plus in the lower half of its industry. The industry median Net Margin % is 2.92. Simulations Plus' value of 18.67% is 540.5% above this benchmark. While the company's 10-year median is 22.80 vs. the industry median of 2.92, Simulations Plus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current Net Margin % of 18.67% is 540.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current Net Margin % is 18.67%, which is 18% below median its own 10-year median of 22.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $38.31, compared to a current price of $18.38 — trading 52% below its estimated fair value. The current Net Margin % is 18.67%, which is 18% below median its 10-year median of 22.80 and 540.5% above the Healthcare Providers & Services industry median of 2.92. Simulations Plus' overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Simulations Plus (SLP), the current Net Margin % is 18.67% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simulations Plus (SLP) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of $18.38 is trading 52% below its estimated GF Value™ of $38.31. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for SLP:

  • Net Margin %: 18.67% (18% below median its 10-year median of 22.80)
  • GF Value™: $38.31 vs. price of $18.38 (52% below fair value)
  • GF Score™: 81/100 with 7 warning signs
  • Industry Position: 540.5% above the Healthcare Providers & Services median (#592 of 664)

No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Simulations Plus Business Description

Other Exchanges SD3:Germany
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
81GF Score

Get the complete analysis for SLP

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.38
Price
$38.31
GF Value